好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Beyond Atrial Shunt-A Comprehensive Study of Echocardiogram Findings and Their Association with Adverse Vascular Events in Patients with Migraine
Headache
S23 - Hot Topics in Headache Medicine (2:24 PM-2:36 PM)
008

To compare the prevalence of echocardiographic findings between patients with migraine with aura (MwA) and without aura (MwoA) and to investigate their ability to predict future adverse vascular events.

Migraine is associated with a higher risk of adverse vascular events. In patients with migraine, there is also a higher prevalence of certain echocardiographic findings such as patent foramen ovale. However, little has been reported for other echocardiographic features, and their association with adverse vascular events is unknown.

In this retrospective cohort study, adult patients with migraine who had transthoracic echocardiogram (TTE) from 2000 to 2020 were identified. The first TTE was defined as the index TTE. Using our institution’s echocardiography dictionary which contained >2000 findings, we compared the findings between MwA and MwoA. We then used the findings as predictors of a composite outcome of adverse vascular events including acute myocardial infarction, acute ischemic stroke, venous thromboembolism and death.

A total of 12778 patients were included. Mean age was 47.2 ± 16.2 years, and 2619 (20.5%) were male. The median follow-up was 64 months, and 3094 (24.2%) had adverse vascular events. Overall, patients with MwA had higher prevalence of shunt, regional wall motion abnormalities (RWMA) and abnormalities in all valves and chambers on index TTE. Multivariable Cox regression models showed that, after adjustment for age, sex, aura and baseline comorbidities, RWMA (adjusted hazard ratio [aHR]: 1.51 [1.26–1.80]) and abnormalities in left ventricle (HR: 1.34 [1.24–1.46]), tricuspid valve (aHR: 1.15 [1.06–1.24]), right atrium (aHR: 1.14 [1.04–1.26]) and right ventricle (aHR: 1.52 [1.34–1.72]) were associated with increased risk of adverse vascular events.

Our results, based on a detailed echocardiographic registry, showed that many subtle cardiac anatomic and physiologic abnormalities might contribute to adverse vascular outcomes in patients with migraine.

Authors/Disclosures
Ping-Hao Yang, MD
PRESENTER
Dr. Yang has nothing to disclose.
Nan Zhang Nan Zhang has nothing to disclose.
Chieh-Ju Chao No disclosure on file
Francisco Lopez-Jimenez, MD The institution of Dr. Lopez-Jimenez has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Anumana. Dr. Lopez-Jimenez has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novo Nordisk. Dr. Lopez-Jimenez has stock in Colibri . The institution of Dr. Lopez-Jimenez has received research support from Anumana. Dr. Lopez-Jimenez has received intellectual property interests from a discovery or technology relating to health care. Dr. Lopez-Jimenez has received publishing royalties from a publication relating to health care.
Kathryn Mangold, PhD Dr. Mangold has received intellectual property interests from a discovery or technology relating to health care.
Zachi Attia Zachi Attia has received personal compensation in the range of $0-$499 for serving as a Consultant for Anumana. Zachi Attia has received personal compensation in the range of $0-$499 for serving as a Consultant for XAI. Zachi Attia has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Pfizer.
Paul Friedman Paul Friedman has received intellectual property interests from a discovery or technology relating to health care. Paul Friedman has received intellectual property interests from a discovery or technology relating to health care. Paul Friedman has received intellectual property interests from a discovery or technology relating to health care.
Peter Noseworthy Peter Noseworthy has nothing to disclose.
Chia-Chun Chiang, MD (Mayo Clinic) Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aruene Corporation . Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Chiang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. The institution of Dr. Chiang has received research support from American Heart Association. The institution of Dr. Chiang has received research support from Lundbeck. The institution of Dr. Chiang has received research support from Pfizer.